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Recent studies have shown that transcription and alternative splicing can be mechanistically coupled. In the EPB41 (protein 4.1R) and
EPB41L3 (protein 4.1B) genes, we showed previously that promoter/alternative first exon choice is coupled to downstream splicing events in
exon 2. Here we demonstrate that this coupling is conserved among several vertebrate classes from fish to mammals. The EPB41 and EPB41L3
genes from fish, bird, amphibian, and mammal genomes exhibit shared features including alternative first exons and differential splice acceptors in
exon 2. In all cases, the 5V-most exon (exon 1A) splices exclusively to a weaker internal acceptor site in exon 2, skipping a fragment designated as
exon 2V. Conversely, alternative first exons 1B and 1C always splice to the stronger first acceptor site, retaining exon 2V. These correlations are
independent of cell type or species of origin. Since exon 2V contains a translation initiation site, splice variants generate protein isoforms with
distinct N-termini. We propose that these genes represent a physiologically relevant model system for mechanistic analysis of transcription-
coupled alternative splicing.
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through a variety of cellular mechanisms, a major one being
alternative splicing of pre-mRNAs. It is estimated that as
many as 60% of human gene products undergo differential
splicing, with many transcripts having multiple splicing
patterns and some having thousands [1–3]. This RNA
processing can lead to differences in exon composition at
the 5V end, within the internal coding regions, or at the 3V end
[4,5]. Since this regulated inclusion or exclusion of selected
exons allows the synthesis of multiple protein isoforms that
possess unique biological properties, polypeptide variants
from the same gene can engage in vastly different cellular
processes.
Many cis-acting regulatory sequences that strongly influ-
ence splicing efficiency have been identified in the RNA
within or near regulated alternative exons [6]. In addition, a
number of trans-acting splicing factors that interact at these
sites to control splicing decisions have been characterized,0888-7543/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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thought to play a key role in regulation. However, the manner
in which these elements are spatially and temporally
integrated with other RNA processing events in the nucleus
is not well understood. An abundance of data supports the
general hypothesis that downstream processes such as RNA
splicing and polyadenylation are mechanistically coupled to
upstream transcriptional events [7–10]. Recent studies have
demonstrated, moreover, that transcription can also be
coupled to alternative pre-mRNA splicing; i.e., the nature of
the transcriptional promoter can influence the ability of
known splicing factors to enhance the efficiency of inclusion
of specific alternative exons [11,12]. In addition, coactivator
proteins that enhance steroid hormone receptor transcription
and alter its splicing have recently been reported, further
reinforcing this concept [13].
In previous studies, we presented evidence of coupling
between transcription and alternative splicing in the EPB41
and EPB41L3 genes (also known as protein 4.1R and 4.1B,
respectively) of human and mouse [14,15]. Specifically, both
EPB41 and EPB41L3 possess alternative first exons that are5) 701 – 707
www.el
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acceptor sites in downstream exon 2. For example, EPB41
gene transcription is driven from three different promoters
and produces three classes of transcripts with different first
exons. These exons, termed 1A, 1B, and 1C, are distin-
guished by their distant location from the coding exons (72–
100 kb), as well as their specificity in splicing to exon 2.
Whereas exon 1A splices to exon 2 to exclude a small portion
at the 5V end (termed exon 2V), transcripts with 1B and 1C
include the small exon 2V region along with the main body of
exon 2. As there is a start codon located in exon 2V, this
alternative splicing effects a switch in translation initiation,
which results in different protein products: 80 kDa (1A) vs
135 kDa (1B and 1C) [14]. A precisely analogous pattern is
also observed for EPB41L3, involving multiple far-upstream
promoters/first exons and their differential splicing to
alternative splice acceptor sites in exon 2 [15].
The goal of the current study was to explore the
evolutionary conservation of putative transcription-coupled
splicing in the protein 4.1 genes among various vertebrate
classes. Here, we report that the N-terminus complexity of
EPB41 and EPB41L3 genes has been preserved across
vertebrate classes from fish to mammals. Moreover, the first
exons in all of these organisms follow strictly defined splicing
patterns to alternative acceptor sites in exon 2, identical to thatFig. 1. Multiple first exons are present in the EPB41/EPB41L3 genes in several verte
two alternative first exons have been identified in the dog, frog, and chicken: one eac
predicted exon 1A has also been found in a zebrafish transcript. However, since the z
time. Note that the alternative first exons are distinguished by their large separation from
exonswere also found forEPB41L3 from human to fish, except for chicken. The small
distinct types of exons based on their splicing pattern to exon 2/2V. AUG1 representsobserved in the human. These results indicate that the coupling
between upstream promoters and downstream alternative
splicing has been conserved for at least 500 million years
and suggest that the 5V complexity of the EPB41/EPB41L3
genes plays a critical but underappreciated role in regulating
expression of these genes encoding essential cytoskeletal
adaptor proteins. These genes may offer a physiologically
relevant model system for studying mechanisms of coupling
between transcription and alternative splicing.
Results
Complex 5V gene structure is phylogenetically conserved in the
EPB41/EPB41L3 genes across several vertebrate classes
Previous studies have shown that the mouse Epb4.1 and
Epb4.113 genes, like those in human, also possess alternative
first exons [14,15]. In this study, we analyzed genetic databases
and recent genome assembly data to examine phylogenetic
conservation of EPB41 and EPB41L3 gene organization
among other vertebrate classes. For mammals, comparative
genomics revealed strong orthologs of EPB41 exons 1A and
1C and EPB41L3 exons 1A and 1B in the dog (Fig. 1), as well
as in the chimp, rat, and cow (data not shown). The authenticity
of these first exons is supported by their high homology to thebrate classes. (A) 5V gene organization of EPB41 for the various species. At least
h from the 1A and 1B/C type. In zebrafish a good candidate 1B/C is indicated; a
ebrafish genome assembly is currently incomplete, its identity is uncertain at this
the downstream exon 2. (B) First exon organization forEPB41L3. Multiple first
numbers between the exons indicate distance in kilobases. 1A, 1B, and 1C refer to
the start codon located in exon 2V found in all species examined.
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upstream of exon 2, and in many cases their representation in
bona fide cDNAs from the various species (see below).
For other vertebrate classes such as birds, amphibians, and
fish, the orthologous first exons could not be identified directly
by genome comparison, presumably due to sequence diver-
gence among these noncoding exons. Therefore, we used a
different strategy for identifying their alternative first exons.
The alternative approach for finding first exons involved
retrieving species-specific EPB41 and EPB41L3 transcripts
from the genetic databases, screening for clones that contain
sequences extending upstream of exon 2, and then mapping the
5V-end sequences of these transcripts back to the cognate
genome assemblies. Using this method, we were able to
identify alternative exons for both genes in nearly all of the
nonmammalian vertebrates considered in this study, including
EPB41 orthologs of chicken, frog, and zebrafish (1B/C only),
as well as EPB41L3 orthologs of frog and zebrafish (Fig. 1). A
candidate zebrafish EPB41 exon 1A has also been identified,
but this assignment is tentative due to the fact that its sequence
is not yet represented in the zebrafish genome assembly.
Based on these data, the overall organization of the 4.1
genes has been conserved for at least 500 million years back to
the emergence of fish. An intriguing feature of this structure is
the very long 5V intronic distances that have been evolutionarily
preserved. Although the zebrafish genome assembly is not yet
complete for these large 4.1 genes, a consistent pattern emerges
from other vertebrate classes in which intron length increases
with time up to mammals. For example, whereas the distance
from EPB41 exon 1A to exon 2 is approximately 49 kb in the
frog and 56 kb in the chicken, in the human genome these
exons are separated by ¨100 kb. Similarly, EPB41L3 exon 1A
is 85 kb upstream of exon 2 in the frog, but ¨141 kb distant
from exon 2 in human.
Since in the dog, chicken, frog, and zebrafish we could
not find both 1B and 1C orthologs for either EPB41 or
EPB41L3, we organized the first exons of the vertebrates in
this study into two distinct groups: the 1A type and the 1B/C
type. The 1A type represents the farthest upstream (most 5V)
first exon, and the 1B/C type represents the remaining first
exon(s). This positional classification was also accompanied
by functional correlates: exons 1A consistently exhibited a
splicing pattern that was distinct from all exons 1B and 1C
(see also below).
Alternative first exons splice to different acceptor sites in
exon 2
From earlier studies of EPB41 and EPB41L3 alternative
first exons in the human and mouse, it was shown that these
exons possess their own transcriptional promoters and that
they splice differently to downstream acceptor sites in exon 2
[14,15]. This unique splicing paradigm suggested coupling
between upstream transcription events and downstream
alternative splicing events (Fig. 2A). For both EPB41 and
EPB41L3, the alternative first exons can be classified into
two distinct types based on their splicing to exon 2. Onecategory, involving the most upstream exon (1A), splices to
an internal acceptor site in exon 2 and excludes a small
portion at the 5V end (exon 2V). Since there is a start codon in
exon 2V, this skipping leads to translation initiation much
farther downstream in exon 4, using an AUG2 that is
conserved in all species examined. In contrast, first exons
of the 1B/C type splice to the first acceptor site in exon 2 so
as to include exon 2V. As it leads to alternative start codon
usage, this differential splicing creates protein isoforms.
To determine whether the strict coupling between first exon
choice and downstream exon 2 splicing is also conserved
among vertebrate species other than human and mouse, we
undertook a survey of EPB41 and EPB41L3 transcripts in the
GenBank database. Representative transcripts were analyzed
not only from dog, chicken, frog, and zebrafish genomes (Figs.
2B and 2C), but also from orangutan, pig, rat, cow, and horse
(not shown). This analysis demonstrated unequivocally that,
for all of these organisms, the 5V-most exon (1A) always splices
to the internal (distal) acceptor site in exon 2, while the
succeeding first exon(s) of the 1B/1C type always splices to the
more proximal site. This is a very robust observation, since a
combined total of 35 cDNAs of type 1A and 30 cDNAs of type
1B/C always obeyed this coupling rule, independent of species
or tissue type.
Although both the proximal and the distal splice sites are
used, these acceptors are very disparate in quality. Using an
algorithm designed to estimate splice site strength (see
Materials and methods), we found that the pyrimidine-rich
proximal acceptor site, without exception, is the much
stronger one for both EPB41 and EPB41L3 in all species
tested (Fig. 3). The internal (distal) splice sites are consis-
tently more purine-rich and score much lower for predicted
acceptor site strength. For instance, the proximal site of
EPB41 from human to fish is on average 86.6 T 1.78,
compared to the distal site_s average value of 70.9 T 1.79.
Discrepancy between the two sites is even more pronounced
for EPB41L3. For this gene, the proximal site has an average
splice value of 92.7 T 1.82, while for the distal site, the value
is 67.88 T 1.21 (excluding the zebrafish datum, which is
unusually low). The conclusion from these data is that cells
must possess an active regulatory mechanism to facilitate the
consistent and selective splicing of 1A-type exons across
large introns to the weaker distal acceptor site in exon 2.
Conservation of exon 2V primary sequences
Although the EPB41 and EPB41L3 first exons do not
exhibit primary sequence conservation across vertebrate
classes, in contrast the short exon 2V region is highly
conserved from human to zebrafish (Table 1). For EPB41,
the length of exon 2V from human to fish is essentially fixed
(17 T 1 nt), whereas exon 2V in EPB41L3 varies from 21 nt
(chicken and frog), to 27 nt (mouse, rat, cow, zebrafish), to 33
nt (human and dog). Sequence alignments revealed significant
identity of exon 2V between EPB41 and EPB41L3 among the
species, especially in an 11-nt region spanning the translation
start site. Here, there is a motif AYCATGACRAC that is
Fig. 2. The multiple first exons splice to different acceptor sites in downstream exon 2. (A) Alternative first exons of the EPB41 and EPB41L3 genes can be
classified into two distinct categories based on their splicing pattern to exon 2. The exon farthest upstream, designated type 1A, splices to an internal acceptor site in
exon 2; the more downstream first exons, denoted type 1B/C, splice to exon 2 to include exon 2V. This leads to alternative use of start codons (denoted by AUG1/
AUG2 and asterisks). (B) The accession IDs of the various EPB41 cDNA clones found for each species. The first exons of these clones can be classified without
exception into either the 1A or the 1B/C type. (C) The accession IDs of the cDNA clones found for EPB41L3 in the various species are listed here. Again, the 5V ends
can be categorized into either the 1A or the 1B/C type based on their splicing pattern to exon 2/2V. .More than one clone available. *Exon deduced by homology to
human exon ortholog.
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deviations. Functionally, this conserved sequence is required
for translation initiation at ATG1; it could also potentially
function in the selection of the distal splice site for exons 1A.
In the mouse and human genes for EPB41 and EPB41L3,
skipping of exon 2V prevents translation of exon 2 sequences,
leading to translation initiation at ATG2 downstream in exon 4.
This results in synthesis of protein isoforms with shorter N-
terminal domains [14,15]. Since the ATG2 in exon 4 is present
and conserved in all the species examined (data not shown),
this supports the notion that the same mechanism operates in
the 4.1 genes of avians, amphibians, and fish.Discussion
This study demonstrates that complex 5V gene structure is
phylogenetically conserved across several vertebrate classes for
the genes encoding two members of the protein 4.1 family of
cytoskeletal proteins: EPB41 and EPB41L3. For these genes
from fish to mammals, genome and transcript analyses reveal
multiple alternative first exons that map far upstream of the
coding regions, as well as unique splicing patterns for these
exons to specific splice acceptor sites in exon 2 that result in
differential translation initiation. The most remarkable finding is
that, despite the long intronic sequences that separate these first
Fig. 3. The splice sites in exons 2/2V have unequal strength. (A) Schematic
showing the alternative splice sites at the exon 2 and 2V junction. The first splice
acceptor has been designated the proximal site and the internal acceptor as the
distal site, based on their relative proximity to the upstream exons. (B) The
estimated splice strengths of alternative 3V splice acceptors of EPB41 exon 2V
for the species examined in this study. The data indicate a clear discrepancy in
splice site quality. The difference is even more dramatic for that of EPB41L3,
shown in C.
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obeyed paradigm: transcripts that initiate at exon 1A always skip
exon 2V, while transcripts that start at exons 1B/C always include
exon 2V (Fig. 4). This specific splicing is observed across many
tissue sources and in diverse vertebrate classes ranging from fish
to mammals (this study, [14]).
Since exons 1A and 1B/C have been associated with
independent transcriptional promoters, it is assumed that the
splicing correlations of 4.1 transcripts are due to coupling
between transcription and alternative splicing. Promoter
activity has been demonstrated for flanking, upstream
sequences of human EPB41 exons 1A and 1B, as well as
EPB41L3 exons 1A and 1B, using luciferase as a reporter
[14,15]. Since other mammalian exons in this study share
significant sequence identity with the human orthologs, this
strongly suggests their authenticity as being true first exons.
For the nonmammalian vertebrates, the strong similarity in
genomic organization and splicing patterns to exon 2V/2
suggests these exons as being functionally homologous first
exons with associated promoter activity. In addition, analysis
of 5V sequences in dozens of 4.1 cDNAs from multiplevertebrate species revealed no evidence of any exons
upstream of those designated here as first exons.
An intriguing issue surrounding these first exons is their
ability to discriminate, from a position tens of kilobases
upstream of exon 2, between splice acceptor sites that are
only 17–33 nt apart. Computational analyses indicate that the
proximal and distal acceptor sites exhibit dramatic differences
in intrinsic splice site ‘‘strength’’—with the former always
stronger than the latter—suggesting that the first acceptor
would likely be the default splice site. Future mechanistic
studies will need to explain how exon 1A can selectively
bypass the stronger acceptor to choose the apparently weaker
site just downstream.
One attractive hypothesis is that there is a physical and
functional coupling between transcription and alternative
splicing [11–13,18]. Since the long CTD repeat domain of
the RNA Pol II large subunit has been proposed as a platform
for assembly of protein complexes required for downstream
RNA processing events, it may also serve a similar function
for proteins that mediate alternative splicing decisions [19–
23]. A number of interesting proteins that can interact with
both CTD and RNA have been identified as potential
candidates for coupling of transcription and splicing. Among
these are SAF-B, SCAFs (SR-like CTD-associated factors),
TLS/FUS-related proteins, p54nrb/PSF, and U2AF65-related
proteins CAPERa and CAPERh [24–30,13,18]. But how
might promoter structure influence alternative splicing? If
loading of splicing cofactors onto the CTD is influenced by
promoter-specific regulatory elements, then it is easy to
speculate that the promoters associated with each alternative
first exon might assemble different cofactors that determine
the splicing pattern at exon 2V/2. The observed ability of
CAPERa and CAPERh to modulate downstream alternative
splicing specifically from steroid hormone-responsive, but not
nonresponsive, promoters represents a precedent for this type
of model [13].
Alternatively, the promoter might influence downstream
splicing events in a couple of other ways. The promoter may
recruit molecules that can phosphorylate the CTD. Since
phosphorylated CTD has been shown to be much stronger in
activating the spliceosomal assembly than its nonphosphory-
lated form, molecules that alter the level of CTD phosphor-
ylation can have a potent impact in splicing regulation [31].
Finally, promoters might also influence splicing events by
recruiting factors that can manipulate transcription kinetics. It
has been reported that introduction of transcriptional pause
sites downstream of a weak splice site can improve its
efficiency of recognition by the spliceosomal machinery
[32,33]. However, this particular model is difficult to
reconcile for the regulated splicing events at EPB41 and
EPB41L3 exon 2V. Since the stronger splice acceptor site is
transcribed before the weaker competing site, it is not
apparent how transcriptional pausing could impart a kinetic
advantage for the weaker site.
Regardless of its exact mechanism, the differential
splicing of alternative exons to acceptor sites in their
downstream exon 2 has important functional ramifications
Table 1
Conservation of exon 2V in EPB41 and EPB41L3
The nucleotide sequences of exon 2V in both (A) EPB41 and (B) EPB41L3 for all the species examined are shown here. There is an 11-nt sequence, marked by the
motif AYCATGACRAC (highlighted box), which is conserved for both EPB41 and EPB41L3 among all the species. This stretch of sequence may play an important
role in the selection of the distal splice site for exon type 1A. The start codon in exon 2V is highlighted in red.
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expression of the translation initiation site in exon 2V,
upstream transcriptional events ultimately regulate the
synthesis of protein isoforms with very different N-terminal
domains. Since the N-terminal domain in the longer isoform
of EPB41 (135 kDa) can significantly alter the binding of
EPB41 to membrane proteins such as band 3 and
glycophorin C, transcription-splicing regulation may be an
essential determinant of important biological properties of
the protein [34]. The observation that this mechanism has
been extant for many millions of years of evolution further
supports its biological importance as a method of gene
regulation and expression.
Finally, we speculate that coupling between transcription
and alternative splicing may be far more widespread than is
currently appreciated. The clear manifestation of this phenom-
enon in the 4.1 genes is due to involvement of independent first
exons with completely distinct nucleotide sequences repre-
sented in the mature mRNAs. It is entirely possible that a
similar coupling occurs in many genes in which no such
‘‘sequence tag’’ remains at the 5V end of the mRNA. Precedence
for such a model has been reported using synthetic constructs to
show that an alternative exon-containing minigene can exhibitFig. 4. Summary of first exon splicing to downstream acceptor sites in exons 2/
2V. Transcription initiated from the most upstream exon (1A) leads to the
selection of the weaker, more distal splice site in exon 2, while transcription
from more downstream first exons (1B/C) allows the use of the stronger, more
proximal splice acceptor. In this study, this paradigm is followed without
exception among all the exons examined. The use of the much weaker splice
site for the 1A class of first exons strongly suggests a special mechanism
coupling transcription to splicing.different splicing efficiencies when transcriptionally activated
by different promoters [11,12]. An analogous situation could
apply to natural endogenous genes by assembly of functionally
distinct transcription complexes, involving alternative enhancer
cofactors, without overt changes in the 5V end of the transcribed
RNA. In such cases the transcription-alternative splicing
connection would be impossible to discern from mRNA
analysis alone. Future studies will be needed to investigate this
hypothesis.
Materials and methods
Identification of alternative EPB41/EPB41L3 5V exons in various
vertebrate classes
Alternative 5V exons of the human and mouse EPB41/EPB41L3 genes were
identified in earlier studies through genetic database searches (GenBank and the
UCSC genomics Web site, http://www.genome.ucsc.edu) and RACE experi-
ments [14,15]. To identify alternative 5V exons in the EPB41/EPB41L3
orthologs of the dog (Canis familiaris), chicken (Gallus gallus), frog (Xenopus
tropicalis), and zebrafish (Danio rerio), the exon 2 sequences of human EPB41
and EPB41L3 were first used in BLAT searches in the UCSC genomics
database to identify their orthologs in these species. Once the orthologs were
identified, alternative 5V sequences for this gene were analyzed through
identification of existing, known clones. In cases for which no submitted data
were available, putative first exons were deduced through homology to the
human first exon (1A, 1B, or 1C) sequences; sequences that showed significant
identity to the human exons and that mapped upstream of exon 2 in the
expected locations were accepted as orthologs. This approach led to the
identification of multiple first exons for both EPB41 and EPB41L3 in almost
all of the species analyzed. Note that the zebrafish EPB41 clone extends the
previously reported 5V sequence so as to include the bona fide translation
initiation site AUG1, which encodes an N-terminal tetrapeptide MTTD, highly
homologous to the mammalian MTTE N-terminal motif [16].
Analysis of splice site strength in exon 2/2V of EPB41/EPB41L3
Splice site strengths of both the proximal and the distal acceptors in exon
2/2V were computed using a special program (http://www.genet.sickkids.on.ca/
~ali/splicesitescore.html) [17]. To compute the acceptor scores, a 15-bp
sequence was inputted into the program; this sequence consisted of 14 bp
before and 1 bp after the splice junction. Although this program is designed
J.S. Tan et al. / Genomics 86 (2005) 701–707 707for human genes, it was used to assess the splice acceptors for all the species
considered in this study; since splice sites are well conserved through
evolution, it is assumed that the program would also be applicable to
nonhuman species.
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